After investigating the patients taking GLP1 analogs (liraglutide, dulaglutide, semaglutide, and semaglutide) for diabetes mellitus, and undergoing EGD, Kobori at al concluded that GLP1 analogs were associated with increased gastric residue [23]. This evidence concerns the gene GLP1R and diabetes mellitus.